You are here

diabetes

Why Novo Nordisk Expects Double-Digit Growth in Diabetes Care in 2016

Market Realist

Fri, 09/30/16 - 01:06 pm

Novo Shows Its Devotion To Tresiba's Cause

Seeking Alpha

Wed, 09/28/16 - 10:20 am

Diabetes drugs are badly needed, but rarely make it to market

Stat/Pharmalot

Tue, 09/27/16 - 09:46 am

clinical trials

Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug

Market Realist

Mon, 09/26/16 - 09:58 am

type 2 diabetes

MannKind - Take A Deep Breath, Afrezza Sales Numbers Are Tough To Swallow

Seeking Alpha

Tue, 09/20/16 - 08:36 pm

inhaled insulin

Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent

Yahoo/Reuters

Sat, 09/17/16 - 01:16 pm

Novo pulls 71,000 kits of glucagon med from US market

BioPharma Dive

Thu, 09/15/16 - 07:20 pm

GlucaGen HypoKit

Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial

Marketwatch

Thu, 09/15/16 - 09:50 am

clinical trials

Will Sanofi See More Growth from Its Blockbuster Insulin Drug?

Market Realist

Thu, 09/15/16 - 09:33 am

Sanofi is teaming with Verily on a $500M JV aimed at marrying tech with diabetes drugs

Endpoints

Sun, 09/11/16 - 09:55 pm

Pfizer seeds diabetes upstart AnTolRx with cash and an option deal

Endpoints

Thu, 09/8/16 - 09:29 am

type 1 diabetes

Novo Nordisk faces delay for insulin combo

BioPharma Dive

Tue, 09/6/16 - 11:03 am

MRK: How Merck's Stock Price Rose 31.42% in 6 Months

Investopedia

Mon, 09/5/16 - 10:01 am

Bristol-Myers Squibb

MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect

Seeking Alpha

Fri, 09/2/16 - 10:26 pm

Express Scripts puts pricing cap on diabetes drugs

BioPharma Dive

Wed, 08/31/16 - 08:59 pm

Express Scripts

Diabetes prevalence varies widely across US, study shows

BioPharma Dive

Thu, 08/25/16 - 09:55 am

Roche launches next-gen glucose monitor

Mass Device

Wed, 08/24/16 - 05:41 pm

blood glucose monitoring

Novo Nordisk Vs. Oramed - A Second Look At The Battle For Oral Insulin

Seeking Alpha

Mon, 08/22/16 - 10:10 pm

Sanofi can’t even buy a break now, as rival Novo speeds ahead on diabetes showdown

Endpoints

Mon, 08/22/16 - 11:41 am

MannKind turns to digital, social media to spread the word on Afrezza's relaunch

Fierce Pharma

Mon, 08/15/16 - 09:44 pm

Pages